Search results
Why Eli Lilly's Immunology Prospects Look Promising
Motley Fool· 2 years agoTop pharmaceutical company Eli Lilly's (NYSE: LLY) diabetes division achieved a key milestone with the approval of Mounjaro in May for type 2 diabetes....
How Evangeline Lilly's decision to shave her head led to her new look in 'Ant-Man and the Wasp:...
Yahoo Movies via AOL· 1 year agoEvangeline Lilly as 'Wasp in Ant-Man and the Wasp: Quantumania' (Photo:Marvel/Walt Disney Studios...
FDA approves first alopecia treatment for condition that causes sudden hair loss
NBC News via Yahoo News· 2 years agoCan hair grow back after alopecia? FDA approved first alopecia treatment for people suffering from a...
Eli Lilly Dives After A 'Bump In The Road' Shakes Its Newest Diabetes Drug
Investor's Business Daily· 1 year agoEli Lilly experienced a "bump in the road" for its newest diabetes treatment, Mounjaro, an analyst...
What to know about Zepbound, Eli Lilly’s new weight loss drug
NBC News via Yahoo News· 7 months agoA new weight loss drug has been approved that promises to be the most effective medication yet. How...
Factbox-What to know about Eli Lilly's new obesity drug
Reuters via Yahoo News· 7 months agoThe once-weekly injection, which contains the same active ingredient as Lilly's big-selling type 2...
Lilly gene therapy finding puts focus on hearing loss treatment pipeline
BioPharma Dive via Yahoo Finance· 5 months agoAn 11-year-old boy born deaf can hear after receiving Lilly's genetic medicine. Others, including...
Evangeline Lilly's New Buzz Cut Steals the Spotlight at 'Ant-Man and the Wasp: Quantumania' Premiere
ET Online via AOL· 1 year agoEvangeline Lilly stole the spotlight at the U.K. premiere of Ant-Man and the Wasp: Quantumania. On...
Lilly (LLY), Incyte's Olumiant Gets FDA Nod for Alopecia Areata
Zacks via Yahoo Finance· 2 years agoEli Lilly LLY and partner Incyte INCY announced that the FDA has granted approval to their oral JAK...
Possible Ozempic side effects, including hair loss, probed by FDA
CBS News via Yahoo News· 5 months agoEditor's note: This story has been updated with the FDA saying its preliminary evaluation has not...